In line with these results, clinical studies confirmed the therapeutic value of PDE inhibitors, such as exisulind, in the prevention of colorectal polyp formation in patients with familial adenomatous polyposis (FAP) (132, 133). The gene discussed is ALDH7A1; the disease is Familial adenomatous polyposis.